TL;DR
This study reveals that during osteoclast differentiation, a key metabolic enzyme, citrate synthase, becomes "succinylated" (a post-translational modification) in response to RANKL signaling. This succinylation directly reduces citrate synthase activity, shifting the cell's energy production towards glycolysis, and ultimately impacts osteoclast development. This work highlights protein succinylation as a critical regulator of osteoclast metabolism and function.
What Problem Does This Paper Address?
Osteoclasts are crucial cells for bone remodeling, and their differentiation from precursor cells is tightly regulated by signaling molecules like RANKL. This process involves significant metabolic shifts to fuel the energy-intensive functions of osteoclasts. While changes in glycolysis and oxidative phosphorylation are known to occur, the precise molecular mechanisms controlling these metabolic adaptations, particularly at the post-translational modification level, remain incompletely understood. Specifically, the role of protein succinylation, a modification linked to metabolic regulation, in osteoclastogenesis was largely unexplored. This paper aims to elucidate the "succinylome" of differentiating osteoclasts and identify key proteins and pathways regulated by succinylation in this context.
Methods
The researchers employed a multi-pronged approach:
- Cell Culture and Differentiation: RAW 264.7 macrophage cell lines and primary bone marrow-derived macrophages (BMDMs) were used to model osteoclast differentiation, stimulated with RANKL and M-CSF.
- Biochemical Assays: Western blotting was used to assess protein expression levels of key enzymes and signaling molecules (e.g., ACOD1, NFATc1, SIRT5, K-Succ). Intracellular succinate levels were measured using a colorimetric assay. Citrate synthase activity was quantified using a spectrophotometric assay.
- Post-Translational Modification Analysis:
- PTMScan® (Immunoaffinity-based LC-MS/MS): This is the core technique for identifying and quantifying succinylated peptides across the proteome. It involves enzymatic digestion of proteins, enrichment of succinylated peptides using specific antibodies, and subsequent mass spectrometry analysis.
- Immunoprecipitation: Used to specifically isolate and confirm the succinylation status of citrate synthase.
- Functional Assays: Tartrate-resistant acid phosphatase (TRAP) staining was used to assess osteoclast differentiation and fusion.
- Genetic/Pharmacological Manipulation: A SIRT5 inhibitor (MC3482) and diethyl succinate (a succinate mimic) were used to modulate succinylation levels and observe their effects on osteoclastogenesis.
- Bioinformatics: Gene Ontology (GO) analysis was performed to understand the cellular localization and biological processes affected by succinylated proteins.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Succinate Accumulation Drives Succinylation: RANKL stimulation leads to increased intracellular succinate levels, which in turn fuels protein succinylation. This establishes a direct link between the signaling pathway and the modification.
- ACOD1 and SIRT5 as Key Regulators: The enzyme aconitate decarboxylase 1 (ACOD1) is upregulated early in differentiation, promoting succinate accumulation. Conversely, the desuccinylase SIRT5 is upregulated later, suggesting a dynamic regulation of succinylation during osteoclast maturation.
- Citrate Synthase is a Major Target: The proteomic analysis revealed citrate synthase (CS) as a key mitochondrial enzyme that is specifically succinylated upon RANKL stimulation, with its succinylation levels increasing significantly.
- Succinylation Inhibits CS Activity: The study demonstrates that increased succinylation of citrate synthase directly leads to a decrease in its enzymatic activity. This is a crucial finding, linking the modification to a functional consequence.
- Metabolic Shift Towards Glycolysis: The reduced activity of citrate synthase, a central enzyme in the TCA cycle, forces osteoclasts to rely more heavily on glycolysis for energy production, especially during early differentiation.
- Impact on Osteoclast Fusion: While not directly impacting differentiation numbers, increased succinylation (mimicked by diethyl succinate or SIRT5 inhibition) led to smaller osteoclasts, suggesting a role in osteoclast fusion.
Key Results
- RANKL stimulation significantly increased intracellular succinate levels in RAW 264.7 cells.
- Protein succinylation levels peaked at 24 hours post-RANKL treatment and remained elevated.
- Quantitative proteomics identified 19 succinylated proteins, with many localized to mitochondria.
- Citrate synthase (CS) was the only protein showing a statistically significant increase in succinylation after RANKL treatment, with a notable increase at lysine residue K76.
- RANKL treatment decreased citrate synthase activity in a concentration-dependent manner.
- Inhibition of SIRT5 (a desuccinylase) increased global protein succinylation and reduced the number and size of osteoclasts.
- Treatment with diethyl succinate (a succinate mimic) increased protein succinylation and led to smaller osteoclasts, suggesting impaired fusion.
Limitations and Future Work
- Functional Analysis of Succinylation Sites: While many succinylated proteins were identified, the functional consequences of succinylation at specific sites (beyond CS) were not fully elucidated. The authors suggest that further investigation is needed to understand the precise impact of these modifications.
- In vivo Relevance: The study was primarily conducted using cell lines. Future work could explore the role of CS succinylation and its impact on osteoclast function and bone remodeling in vivo.
- Mechanism of CS Succinylation Impact: While the study shows CS succinylation reduces activity, the precise mechanism (e.g., steric hindrance vs. allosteric effects) requires further investigation. The authors propose that K76's proximity to the enzymatic cleft suggests steric hindrance.
- Broader Role of Succinylation in Bone Diseases: The paper notes that the role of protein succinylation in bone-related diseases is largely uninvestigated, suggesting this as a promising area for future research, especially given the link between succinate and inflammatory conditions like rheumatoid arthritis.
- SHMT2 Succinylation Anomaly: The unexpected downregulation of SHMT2 succinylation in RAW 264.7 cells was noted as potentially an artifact of the cell line model, suggesting that studies using primary cells (like BMDMs) might provide more physiologically relevant insights for this specific protein.
Summary updated